Healthcare Industry News

 According to the World Health Organization (WHO), around 900 million people are affected by skin disorders worldwide, at any point in time. The organization also states that skin diseases are among the most common health ailments in the world. Warts, pyoderma, acne, scabies, and eczema are some of the most prevalent skin disorders across the globe. Furthermore, acne and freckles affect most of the U.S. population. According to the National Eczema Association, around 31.6 million people in the U.S. were affected by at least one form of eczema in 2019. Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/dermatology-drug-market/report-sample Due to an escalation in the cases of skin problems, the healthcare system has come up with an array of drugs, which include Humira, Otezla, Enbrel, Neoral, Cubicin, Canesten, Dupixent, Valtrex, Remicade, Stelara, Cosentyx, Taltz, Zyvox, Protopic, and Eucrisa. Of these, dermatologists across the world have begun to pre

 The rising prevalence of chronic diseases such as cancer and various rare diseases is pushing up the demand for gene therapy across the world. This is because gene therapies can treat various rare diseases, especially the ones that are caused because of genetics.  Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/gene-therapy-market/report-sample Similarly, the country witnessed a sharp rise in cancer mortality, from 595,690 to 606,880 from 2016 to 2019. This caused a huge upswing in the popularity of gene therapy in the country. At present, the advancement of the gene therapy industry is being affected by the high production costs, long lead times, high capital demands, and low production volumes. This is boosting the demand for automation in manufacturing operations, which helps companies overcome these constraints.  There are mainly two types of gene therapies performed namely in vivo and ex vivo. Between the two, the popularity of the in vivo gen